1. Libby, P, Ridker, PM, Hansson, GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129–2138.
Google Scholar | Crossref | Medline | ISI2. Fowkes, FG, Rudan, D, Rudan, I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329–1340.
Google Scholar | Crossref | Medline | ISI3. Ridker, PM, Stampfer, MJ, Rifai, N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481–2485.
Google Scholar | Crossref | Medline | ISI4. Franchini, M, Capra, F, Targher, G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007; 5: 14.
Google Scholar | Crossref | Medline5. O'Donnell, J, Boulton, FE, Manning, RA, et al. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335–341.
Google Scholar | Crossref | Medline6. Biancari, F, Satta, J, Pokela, R, et al. ABO blood group distribution and severity of coronary artery disease among patients undergoing coronary artery bypass surgery in Northern Finland. Thromb Res 2002; 108: 195–196.
Google Scholar | Crossref | Medline7. Kaya, A, Tanboğa, İH, Kurt, M, et al. Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease. Anadolu Kardiyol Derg 2014; 14: 55–60.
Google Scholar | Medline8. Pike, MM, Larson, NB, Wassel, CL, et al. ABO blood group is associated with peripheral arterial disease in African Americans: the multi-ethnic study of atherosclerosis (MESA). Thromb Res 2017; 153: 1–6.
Google Scholar | Crossref | Medline9. Jaff, MR, White, CJ, Hiatt, WR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): the TASC steering comittee. Ann Vasc Dis 2015; 8: 343–357.
Google Scholar | Crossref | Medline10. Kukkonen, T, Korhonen, M, Halmesmäki, K, et al. Poor inter-observer agreement on the TASC II classification of femoropopliteal lesions. Eur J Vasc Endovasc Surg 2010; 39: 220–224.
Google Scholar | Crossref | Medline | ISI11. Eskandari, R, Hosseinzadeh, Z, Rezaei, Y, et al. Relationship between ABO blood group and coronary artery disease in patients undergoing elective coronary angiography. Stud Med Sci 2021; 32: 234–242.
Google Scholar12. Capuzzo, E, Bonfanti, C, Frattini, F, et al. The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program. Ann Transl Med 2016; 4: 189.
Google Scholar | Crossref | Medline13. Karabuva, S, Carević, V, Radić, M, et al. The association of ABO blood groups with extent of coronary atherosclerosis in Croatian patients suffering from chronic coronary artery disease. Biochem Med (Zagreb) 2013; 23: 351–359.
Google Scholar | Crossref | Medline14. Parente, EB, Harjutsalo, V, Lehto, M, FinnDiane Study Group, et al. Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status. Cardiovasc Diabetol 2020; 19: 68.
Google Scholar | Crossref | Medline15. Schmitz, G, Kaminski, WE. ABCA2: a candidate regulator of neural transmembrane lipid transport. Cell Mol Life Sci 2002; 59: 1285–1295.
Google Scholar | Crossref | Medline | ISI16. Song, J, Chen, F, Campos, M, et al. Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC Study of 11,673 Subjects. PLoS One 2015; 10: e0132626.
Google Scholar | Medline17. Ruggeri, ZM, Zimmerman, TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895–904.
Google Scholar | Crossref | Medline18. Vischer, UM . von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006; 4: 1186–1193.
Google Scholar | Crossref | Medline | ISI19. Mannucci, PM . von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998; 18: 1359–1362.
Google Scholar | Crossref | Medline | ISI20. Preston, AE, Barr, A. The plasma concentration of factor Viii in the Nnrmal population. II. The effects of age, sex and blood group. Br J Haematol 1964; 10: 238–245.
Google Scholar | Crossref | Medline21. Nydegger, UE, Wuillemin, WA, Julmy, F, et al. Association of ABO histo-blood group B allele with myocardial infarction. Eur J Immunogenet 2003; 30: 201–206.
Google Scholar | Crossref | Medline22. Carpeggiani, C, Coceani, M, Landi, P, et al. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010; 211: 461–466.
Google Scholar | Crossref | Medline | ISI23. Hall, R, Bunch, GA, Humphrey, CS. The frequencies of ABO blood groups and of secretors of ABH group substances in peripheral arteriosclerosis. Atherosclerosis 1971; 14: 241–246.
Google Scholar | Crossref | Medline24. Kingsbury, KJ . Relation of ABO blood-groups to atherosclerosis. Lancet 1971; 297: 199–203.
Google Scholar | Crossref25. Garrison, RJ, Havlik, RJ, Harris, RB, et al. ABO blood group and cardiovacular disease: the Framingham study. Atherosclerosis 1976; 25: 311–318.
Google Scholar | Crossref | Medline26. Ba, DM, Sow, MS, Diack, A, et al. Cardiovascular disease and ABO blood-groups in Africans. Are blood-group A individuals at higher risk of ischemic disease?: a pilot study. Egypt Heart J 2017; 69: 229–234.
Google Scholar | Crossref | Medline27. Chen, Z, Yang, SH, Xu, H, et al. ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Sci Rep 2016; 6: 23250.
Google Scholar | Crossref | Medline28. Rivera-Caravaca, JM, Camelo-Castillo, A, Ramírez-Macías, I, et al. Antithrombotic therapy in patients with peripheral artery disease: a focused review on oral anticoagulation. Int J Mol Sci 2021; 22: 7113.
Google Scholar | Crossref | Medline